We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+6.2%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$9.56B
AUM Growth
+$531M
(+5.9%)
Cap. Flow
+$49.6M
Cap. Flow
% of AUM
0.52%
Top 10 Holdings %
Top 10 Hldgs %
14.04%
Holding
1,755
New
15
Increased
420
Reduced
1,119
Closed
198
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
General Dynamics
GD
|
+$57.1M |
| 2 |
Federal Realty Investment Trust
FRT
|
+$54.9M |
| 3 |
New Jersey Resources
NJR
|
+$10.3M |
| 4 |
Medtronic
MDT
|
+$10.1M |
| 5 |
UMB Financial
UMBF
|
+$10M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Healthpeak Properties
DOC
|
+$48.2M |
| 2 |
CLC
Clarcor
CLC
|
+$15.4M |
| 3 |
Amgen
AMGN
|
+$11.3M |
| 4 |
Apple
AAPL
|
+$9.79M |
| 5 |
Nucor
NUE
|
+$8.91M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.52% |
| 2 | Healthcare | 14.53% |
| 3 | Technology | 12.08% |
| 4 | Consumer Staples | 11.47% |
| 5 | Industrials | 10.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Coherus Oncology
CHRS
$217M
| $659K | 0.01% |
31,180
-2,395
| -7% | -$58.9K |
|
|
FOLD
902
DELISTED
Amicus Therapeutics
FOLD
| $659K | 0.01% |
92,366
-24,545
| -21% | -$155K |
|
|
VR
903
DELISTED
Validus Hold Ltd
VR
| $658K | 0.01% |
11,661
+839
| +8% | +$47.8K |
|
|
HBI
904
DELISTED
Hanesbrands
HBI
| $657K | 0.01% |
31,643
-1,816
| -5% | -$38.5K |
|
|
JNS
905
DELISTED
Janus Capital Group Inc
JNS
| $657K | 0.01% |
49,763
-6,541
| -12% | -$83.6K |
|
|
WOOF
906
DELISTED
VCA Inc.
WOOF
| $657K | 0.01% |
7,180
-1,102
| -13% | -$98.8K |
|
907
ScottsMiracle-Gro
SMG
$4.03B
| $655K | 0.01% |
7,013
-612
| -8% | -$56.7K |
|
908
Liberty Latin America Class C
LILAK
$1.5B
| $653K | 0.01% |
33,125
-936
| -3% | -$18.4K |
|
|
FMI
909
DELISTED
Foundation Medicine, Inc.
FMI
| $653K | 0.01% |
20,262
-5,061
| -20% | -$126K |
|
|
CY
910
DELISTED
Cypress Semiconductor
CY
| $653K | 0.01% |
47,433
-2,194
| -4% | -$28K |
|
911
PTC
PTC
$13.7B
| $647K | 0.01% |
12,321
-1,261
| -9% | -$66.7K |
|
|
ACOR
912
DELISTED
Acorda Therapeutics
ACOR
| $647K | 0.01% |
257
-63
| -20% | -$181K |
|
|
IPXL
913
DELISTED
Impax Laboratories, Inc.
IPXL
| $647K | 0.01% |
51,146
-12,128
| -19% | -$146K |
|
914
Prestige Consumer Healthcare
PBH
$2.35B
| $646K | 0.01% |
11,632
-2,761
| -19% | -$152K |
|
|
PE
915
DELISTED
PARSLEY ENERGY INC
PE
| $646K | 0.01% |
19,869
+6,814
| +52% | +$226K |
|
916
Nabors Industries
NBR
$1.23B
| $644K | 0.01% |
986
-53
| -5% | -$40.5K |
|
917
Kennametal
KMT
$2.68B
| $642K | 0.01% |
16,368
-4,755
| -23% | -$175K |
|
918
ManpowerGroup
MAN
$2.39B
| $641K | 0.01% |
6,245
-821
| -12% | -$79.6K |
|
919
Cognex
CGNX
$10.3B
| $640K | 0.01% |
15,240
-2,098
| -12% | -$76.7K |
|
920
Jack Henry & Associates
JKHY
$10.7B
| $640K | 0.01% |
6,874
-1,029
| -13% | -$94.8K |
|
921
NVR
NVR
$17.2B
| $640K | 0.01% |
304
-52
| -15% | -$98.5K |
|
922
IDEX
IEX
$16.5B
| $639K | 0.01% |
6,837
-962
| -12% | -$88.4K |
|
923
Dycom Industries
DY
$12.9B
| $638K | 0.01% |
6,863
-1,744
| -20% | -$148K |
|
|
CBL
924
DELISTED
CBL& Associates Properties, Inc.
CBL
| $638K | 0.01% |
66,830
-6,141
| -8% | -$63K |
|
|
QCP
925
DELISTED
Quality Care Properties, Inc.
QCP
| $638K | 0.01% |
33,844
-75
| -0.2% | -$1.33K |
|
Similar funds
ProShare Advisors's Q1 2017 Portfolio in Review
As of Q1 2017, ProShare Advisors held 1,755 positions worth $9.56B, up 5.9% from $9.03B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
ProShare Advisors's Q1 2017 filing shows 15 new, 420 increased, 1,119 reduced and 198 closed positions. Its largest new stake was Qiagen: 113,675 shares worth $3.49M. The largest sale was Healthpeak Properties, an estimated $48.2M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.
- ProShare Advisors's largest Q1 2017 buy was Qiagen: 113,675 shares worth $3.49M.
- ProShare Advisors added most to General Dynamics in Q1 2017, an estimated $57.1M increase.
- ProShare Advisors's biggest Q1 2017 reduction was Healthpeak Properties, cutting an estimated $48.2M.
- ProShare Advisors fully exited Clarcor in Q1 2017, selling an estimated $15.4M.
- ProShare Advisors's ten largest holdings make up 14% of its $9.56B portfolio in Q1 2017.
- ProShare Advisors opened 15 new positions and closed 198 in Q1 2017.
- ProShare Advisors's portfolio value rose 5.9% quarter-over-quarter to $9.56B.
Based on ProShare Advisors's 13F filing for Q1 2017, filed 25 Apr 2017.